You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ustekinumab

Showing 51 - 75 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plaque Psoriasis Trial in Worldwide (ABP 654, Ustekinumab)

Completed
  • Plaque Psoriasis
  • ABP 654
  • Ustekinumab
  • Birmingham, Alabama
  • +83 more
Nov 18, 2022

Psoriatic Arthritis Depending on Whether Their Disease is

Completed
  • Psoriatic Arthritis
  • Ustekinumab
  • Lyon Cedex 03, France
    Hôpital Edouard Herriot
May 13, 2020

Graft vs. Host Disease Trial in Tampa (Ustekinumab, Placebo, Tacrolimus (TAC))

Completed
Has Results
  • Graft vs. Host Disease
  • Ustekinumab
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Mar 2, 2020

Uveitis Trial (Ustekinumab)

Withdrawn
  • Uveitis
  • Ustekinumab
  • (no location specified)
Dec 4, 2019

Crohn Disease Trial in Worldwide (Ustekinumab)

Completed
Has Results
  • Crohn Disease
  • Ustekinumab
  • Antwerpen, Belgium
  • +106 more
Aug 6, 2021

Crohn's Disease (CD) Trial in Worldwide (Risankizumab, Ustekinumab)

Recruiting
  • Crohn's Disease (CD)
  • Chandler, Arizona
  • +298 more
Aug 16, 2022

Psoriasis, Cardiovascular Disease Trial in Philadelphia (Ustekinumab, Placebo)

Completed
Has Results
  • Psoriasis
  • Cardiovascular Disease
  • Ustekinumab
  • Placebo
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 14, 2019

Crohn's Disease Trial in Worldwide (Guselkumab Dose 1, Guselkumab Dose 2, Guselkumab Dose 3)

Active, not recruiting
  • Crohn's Disease
  • Guselkumab Dose 1
  • +7 more
  • Dothan, Alabama
  • +574 more
Jan 31, 2023

Active Psoriatic Arthritis Trial in Worldwide (BMS-986165 Placebo, BMS-986165 Dose A, BMS-986165 Dose B)

Completed
Has Results
  • Active Psoriatic Arthritis
  • BMS-986165 Placebo
  • +4 more
  • Huntsville, Alabama
  • +93 more
Jan 25, 2022

Psoriatic Arthritis Trial in Worldwide (Guselkumab, Ustekinumab, Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • Huntsville, Alabama
  • +40 more
Sep 21, 2020

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis Trial in Worldwide (Bimekizumab,

Completed
Has Results
  • Chronic Plaque Psoriasis
  • +2 more
  • Phoenix, Arizona
  • +104 more
Jul 15, 2022

Program Using the Ingenix NHI Database

Completed
  • Psoriasis
  • anti-TNF biologics
  • +4 more
  • (no location specified)
Feb 19, 2019

Psoriasis Trial in Canada, United States (Ustekinumab, Abatacept, UST Placebo)

Completed
Has Results
  • Psoriasis
  • Ustekinumab
  • +3 more
  • Los Angeles, California
  • +9 more
Dec 26, 2018

Plaque Psoriasis Trial in Worldwide (Ixekizumab, Ustekinumab, Placebo)

Completed
Has Results
  • Plaque Psoriasis
  • Wein, Austria
  • +47 more
Jun 10, 2020

Crohn's Disease Trial in Worldwide (Mirikizumab, Ustekinumab, Placebo)

Recruiting
  • Crohn's Disease
  • Birmingham, Alabama
  • +580 more
Aug 17, 2022

Plaque Psoriasis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, ustekinumab)

Terminated
Has Results
  • Plaque Psoriasis
  • 210 mg brodalumab
  • +3 more
  • Birmingham, Alabama
  • +156 more
Dec 17, 2019

IBD, Psoriasis Trial (Ustekinumab, Vedolizumab)

Unknown status
  • Inflammatory Bowel Diseases
  • Psoriasis
  • (no location specified)
Aug 10, 2018

Plaque Psoriasis Trial in Worldwide (Secukinumab, Ustekinumab)

Completed
Has Results
  • Plaque Psoriasis
  • Anniston, Alabama
  • +154 more
Jun 18, 2019

Atopic Dermatitis Trial in New York (Ustekinumab, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Ustekinumab
  • Placebo
  • New York, New York
    Rockefeller University
Feb 15, 2018

Moderate to Severe Plaque Psoriasis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, ustekinumab)

Terminated
Has Results
  • Moderate to Severe Plaque Psoriasis
  • 210 mg brodalumab
  • +3 more
  • Birmingham, Alabama
  • +153 more
Jan 3, 2020

Psoriasis Trial in Worldwide (Ustekinumab, Guselkumab, Placebo for ustekinumab)

Completed
Has Results
  • Psoriasis
  • Ustekinumab
  • +3 more
  • Birmingham, Alabama
  • +86 more
Aug 11, 2017

s on Systemic Inflammation

Completed
  • Psoriasis
  • Inflammation
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Oct 12, 2017

s for Moderate-to-severe Psoriasis

Completed
  • Psoriasis
  • (no location specified)
Aug 10, 2017

Psoriasis Trial in Melbourne (BMS-986202, Placebo, Interferon alpha-2a recombinant)

Completed
  • Psoriasis
  • Melbourne, Victoria, Australia
  • +1 more
Aug 2, 2017

Moderate to Severe Palmar Plantar Psoriasis Trial in Boston (Ustekinumab)

Completed
Has Results
  • Moderate to Severe Palmar Plantar Psoriasis
  • Ustekinumab
  • Boston, Massachusetts
    Tufts Medical Center
Sep 26, 2016